ARPA-H Commits $160M to Personalized Gene Editing

Institution Advanced Research Projects Agency for Health (ARPA-H), U.S. Department of Health and Human Services — THRIVE program (Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines) Event Type Government funding award — performer team selection Value Up to $160 million across performer teams…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *